D1000 Varejo Farma - Public Comps and Valuation Multiples

D1000 Varejo Farma Overview

About D1000 Varejo Farma

D1000 Varejo Farma Participacoes SA invests in national or foreign pharmaceutical retail companies.

Founded

2010

HQ

Employees

n/a

Website

d1000varejofarma.com.br

Sectors

Pharmacies

Financials

Last FY Revenue $406M

Last FY EBITDA $34.0M

EV

$118M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

D1000 Varejo Farma Financials

See D1000 Varejo Farma valuation multiples based on analyst estimates

D1000 Varejo Farma P&L

In the most recent fiscal year, D1000 Varejo Farma reported revenue of $406M and EBITDA of $34.0M.

D1000 Varejo Farma expects next 12-month revenue of XXX and NTM EBITDA of XXX

See D1000 Varejo Farma valuation multiples based on analyst estimates

	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	XXX	$406M	XXX	XXX	XXX
Gross Profit	XXX	$124M	XXX	XXX	XXX
Gross Margin	XXX	31%	XXX	XXX	XXX
EBITDA	XXX	$34.0M	XXX	XXX	XXX
EBITDA Margin	XXX	8%	XXX	XXX	XXX
EBIT	XXX	$11.9M	XXX	XXX	XXX
EBIT Margin	XXX	3%	XXX	XXX	XXX
Net Profit	XXX	$4.9M	XXX	XXX	XXX
Net Margin	XXX	1%	XXX	XXX	XXX
Net Debt	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for D1000 Varejo Farma including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, D1000 Varejo Farma achieved $406M in revenue and $34.0M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	Analyst estimates available to subscribers	$406M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	$124M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	30.6% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	$34.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	8.4% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	$11.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	2.9% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	$4.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	1.2% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for D1000 Varejo Farma

This financial data table provides comprehensive performance metrics for D1000 Varejo Farma, a company based in Brazil. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, D1000 Varejo Farma reported $406M in total revenue.
Fiscal year EBITDA was $34.0M.
The company maintained a gross profit margin of 30.6% in the most recent fiscal year.
EBITDA margin for the fiscal year was 8.4%.
Net profit margin reached 1.2% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for D1000 Varejo Farma. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

D1000 Varejo Farma Stock Performance

D1000 Varejo Farma has current market cap of BRL 240M (or $45.2M), and EV of BRL 627M (or $118M).

Market Cap Evolution

D1000 Varejo Farma Stock Data

As of September 23, 2025, D1000 Varejo Farma's stock price is BRL 5 (or $1).

See D1000 Varejo Farma trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$118M	$45.2M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

D1000 Varejo Farma Valuation Multiples

D1000 Varejo Farma's trades at 0.3x EV/Revenue multiple, and 3.5x EV/EBITDA.

See valuation multiples for D1000 Varejo Farma and 15K+ public comps

D1000 Varejo Farma Financial Valuation Multiples

As of September 23, 2025, D1000 Varejo Farma has market cap of $45.2M and EV of $118M.

Equity research analysts estimate D1000 Varejo Farma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

D1000 Varejo Farma's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$45.2M	XXX	$45.2M	XXX	XXX	XXX
EV (current)	$118M	XXX	$118M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	0.3x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	3.5x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	9.9x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	9.3x	XXX	XXX	XXX
EV/FCF	n/a	XXX	7.6x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get D1000 Varejo Farma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

D1000 Varejo Farma Margins & Growth Rates

D1000 Varejo Farma's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

D1000 Varejo Farma's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

D1000 Varejo Farma's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for D1000 Varejo Farma and other 15K+ public comps

D1000 Varejo Farma Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	8%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	24%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	28%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial